SFXN5 Activators
SFXN5 Activators are a diverse group of chemical compounds that facilitate the enhancement of SFXN5's role as a mitochondrial transporter. Forskolin, by raising cAMP levels, indirectly boosts the activity of SFXN5 through PKA-mediated phosphorylation, enhancing its transport capabilities. Similarly, EGCG's inhibitory effect on various kinases may reduce competitive phosphorylation, thereby promoting SFXN5's functional activity in the mitochondria. S1P, through its activation of G-protein coupled receptors, initiates downstream signaling that could positively influence mitochondrial biogenesis, indirectly supporting SFXN5's transport function. PMA, a PKC activator, potentially augments SFXN5 activity by enhancing mitochondrial membrane potential and, consequently, the efficiency of SFXN5's transport mechanism.
Additionally, compounds like AICAR and Metformin engage AMPK, which triggers mitochondrial biogenesis and fatty acid oxidation, processes that would likely increase demand for SFXN5's transport activity. Resveratrol, through SIRT1 activation and subsequent deacetylation of PGC-1α, indirectly stimulates mitochondrialfunction and may enhance SFXN5's role. Pioglitazone and Nicotinamide mononucleotide (NMN) both act to augment mitochondrial function and biogenesis, indirectly upregulating SFXN5's activity through increased transport needs within the mitochondria. MitoQ's targeted antioxidant properties may preserve mitochondrial integrity, indirectly fostering an optimal environment for SFXN5's function. Finally, compounds like DNP, despite its roles in disrupting oxidative phosphorylation, could paradoxically increase the functional demand on SFXN5, as the mitochondria attempt to compensate for impaired electron transport by increasing substrate transport.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate and enhance the activity of SFXN5 by facilitating its transport function in mitochondria. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits a range of kinases, thereby reducing competitive signaling pathways and indirectly increasing the activity of SFXN5 as a mitochondrial transporter by reducing phosphorylation events that might otherwise inhibit SFXN5's function. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P interacts with its G-protein coupled receptors to activate downstream signaling cascades that include MAPK and PI3K pathways, potentially enhancing the functional activity of SFXN5 by promoting mitochondrial biogenesis and function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can indirectly increase the activity of SFXN5 by stimulating signaling cascades that enhance the mitochondrial membrane potential, thereby possibly increasing the efficiency of SFXN5's transport mechanism. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can enhance mitochondrial biogenesis and function, indirectly supporting the activity of SFXN5 by increasing the demand for its transport activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which in turn can deacetylate and activate PGC-1α, a key regulator of mitochondrial biogenesis. This activation indirectly enhances the activity of SFXN5 by increasing mitochondrial number and function. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin activates AMPK, which promotes mitochondrial biogenesis and enhances fatty acid oxidation. This could indirectly increase the functional activity of SFXN5 by upregulating mitochondrial transport requirements. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR-gamma agonist, promotes the transcription of genes involved in mitochondrial function and may indirectly enhance the activity of SFXN5 through increased mitochondrial biogenesis and fatty acid metabolism. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
NMN is a precursor of NAD+, which is involved in sirtuin activation. Increased NAD+ levels can enhance SIRT1 activity, promoting deacetylation of PGC-1α and thereby supporting mitochondrial function and potentially the activity of SFXN5. | ||||||
Mito-Q | 444890-41-9 | sc-507441 | 5 mg | $290.00 | ||
MitoQ is a mitochondria-targeted antioxidant that may indirectly enhance SFXN5 function by reducing oxidative stress in mitochondria, thus maintaining an optimal environment for SFXN5's transport activity. | ||||||